Inhibition of Myc in vivo leads to sustained tumor regression due to promoting proliferative arrest, apoptosis, differentiation, and cellular senescence in cancer cells, while the anti-proliferative effects in healthy tissues are reversible and minimal [8]. Here, MYC is linked to cancer.